1 |
M. E. Winkler, K. Lerch, and E. I. Solomon, Competitive inhibitor binding to the binuclear copper active in tyrosinase, J. Am. Chem. Soc., 103(23), 7001 (1981)
DOI
|
2 |
A. G. Lowell, Physiology, biochemistry and molecular biology of the skin, 2nd Ed., Oxford University Press Inc., New York, 891 (1991)
|
3 |
S. Tuomaala, S. Eskelin, A. Tarkkanen, and T. Kivela, Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites, Invest. Ophthalmol. Vis. Sci., 43(11), 3399 (2002)
PUBMED
|
4 |
G. T. Lee, J. N. Lee, G. H. Jeong, Y. J. Lee, and S. G. Lee, Cosmetic composit for whitening containing senkunolide A, KP 10-0504408 (1995)
|
5 |
F. Nanjo, K. Goto, R. Seto, M. Suzuki, M. Sakai, and Y. Hara, Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical, Free Radic. Biol. Med., 21(6), 895 (1996)
DOI
ScienceOn
|
6 |
S. H. Lee, J. S. Park, S. Y. Kim, J. J. Kim, and S. R. Chung, The screening of the inhibitory compounds on tyrosinase activity from the natural product, Yakhak Haeji, 41(4), 456 (1997)
|
7 |
JP 1994-60157273
|
8 |
A. Perez-Bernal, M. A. Munoz-Perez, and F. Camacho, Management of facial hyperpigmentation, Am. J. Clin. Dermatol., 1(5), 261 (2000)
DOI
ScienceOn
|
9 |
T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65(1), 55 (1983)
DOI
ScienceOn
|
10 |
K. H. Jeon, B. G. Lee, D. G. Park, and B. S. Lee, Cosmetic composit for whitening containing Broussonetia kazinoki extract, KP 10-0070824 (2001)
|
11 |
H. K. Kim, S. K. Kim, and S. W. Hwang, Daily topical sequential triple therapy of tretinoin, betamethasone valerate and hydroquinone on melasma, Kor. J. Dermatol., 18(6), 529 (1980)
|
12 |
H. Shimomura, Y. Sashida, and Y. Mimaki, Phenolic glycerides from Lilium auratum, Phytochem. 26(3), 844 (1987)
DOI
ScienceOn
|
13 |
K. Kameyama, C. Sakai, S. Kondoh, K. Yonemoto, S. Nishiyama, M. Tagawa, T. Murata, T. Ohnuma, J. Quigley, A. Dorsky, D. Bycks, and K. Blanock, Inhibitory effect of magnesium L-ascorbyl-2- phosphate (VC-PMG) on melanogenesis in vitro and in vivo, J. Am. Acad. Dermatol., 34(1), 29 (1996)
DOI
ScienceOn
|
14 |
A. Perez-Bernal, M. A. Munoz-perez, and F. Camacho, Management of facial hyperpigmentation, Am. J. Clin. Dermatol., 1(5), 261 (2000)
DOI
ScienceOn
|
15 |
J. H. Paik and M. H. Lee, Antimelanogenic effects of arbutin, Kor. J. Dermatol., 38(10), 1303 (2000)
|
16 |
J. H. Park, G. S. Young, U. K. Shin, and S. K. Baek, Tyrosinase inhibition activity of some herbal drugs, Yakhak Haeji, 41(4), 518 (1997)
|
17 |
D. I. Jang, B. G. Lee, C. O. Jeon, N. S. Jo, S. Y. Park, H. Lee, and J. S. Koh, Melanogenesis inhibitor from paper mulberry, Cosme. & Toilet., 112(3), 59 (1997)
|
18 |
H. Shimomura, Y. Sashida, Y. Mimaki, Y. Kudo, and K. Maeda, New phenylpropanoid glycerol glucosides from the bulbs of Lilium species, Chem. Pharm. Bull., 36(12), 4841 (1988)
DOI
|
19 |
H. Ando, Y. Funasaka, M. Oka, A. Ohashi, M. Furumura, J. Matsunaga, N. Matsunaga, V. H. Hearing, and M. Ichihashi, Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis, J. Lipid Res., 40(7), 1312 (1999)
PUBMED
|
20 |
V. J. Hearing, Biochemical control of melanogenesis and melanosomal organization, J. Invest. Dermatol. Symp. Proc., 4(1), 24 (1999)
|
21 |
K. Maeda and M. Fukuda, Arbutin: mechanism of its depigmenting action in human melanocyte culture, J. Pharmacol. Exp. Ther., 276(2), 765 (1996)
PUBMED
|
22 |
J. H. Paik and M. H. Lee, Antimelanogenic effects of arbutin, Kor. J. Dermatol., 38(10), 1303 (2000)
|
23 |
K. Jimbow, H. Obata, M. A. Pathak, and T. B. Fitzpatrick, Mechanism of depigmentation by hydroquinone, J. Invest. Dermatol., 62(4), 436 (1974)
DOI
ScienceOn
|